Effect of Different Ultrasound Doses on Median Nerve Conduction Parameters
NCT ID: NCT05233488
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2022-02-12
2023-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
NCT04092140
Evaluation of Nerve Ultrasound in Detecting Clinical and Subclinical Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus
NCT06187129
Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy
NCT03888872
Efficacy of Noninvasive Radiofrequency in Attenuating Diabetic Neuropathic Pain
NCT05917249
Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.
NCT06615622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low US dose
Pulsed US, 1 W/cm2, 10% duty cycle.
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
Intermediate US dose
Pulsed US, 1 W/cm2, 50% duty cycle.
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
High US dose
Pulsed US, 3 W/cm2, 10% duty cycle.
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
Higher US dose
Pulsed US, 3 W/cm2, 50% duty cycle.
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects assigned will be apparently healthy subjects with no neurological or neuromuscular history affecting the upper limb.
Exclusion Criteria
2. Diabetes mellitus.
3. Previous surgeries or median and/or ulnar nerve release.
4. Cervical radiculopathy.
5. Median or ulnar entrapment neuropathies.
6. Previous or current pregnancies.
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Saadeldeen Shalaby
Lecturer, Faculty of Physical Therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amr S Shalaby, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-43/02/008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.